Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment BIO Q1 2026 Earnings EPS Falls Short of Estimates Shares Gain FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response Antero Resources Q1 2026 Earnings Slight EPS Miss Amid Strong Natural Gas Operations Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction